查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829867

2025年全球植入式輸液幫浦市場報告

Implantable Infusion Pumps Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式輸液幫浦市場穩定成長，市場規模從2024年的195.9億美元成長至2025年的203.2億美元，複合年成長率為3.7%。預測期內的成長歸因於慢性病管理、人口老化、疼痛管理以及監管核准。

植入式輸液幫浦市場規模預計在未來幾年強勁成長，2029年將達到264.9億美元，年複合成長率(CAGR)為6.9%。預測期內的成長歸因於個人化醫療、遠端患者監護、藥物開發和慢性病管理。預測期內的主要趨勢包括微創植入、遠端監測和程式設計、鞘內疼痛管理以及多學科協作。

植入式輸液幫浦是一種先進的藥物輸送系統，旨在透過手術植入患者體內。這些裝置負責將藥物以可控且精確的方式直接輸送到血液中。

植入式輸液幫浦市場細分為病患自控鎮痛 (PCA) 幫浦、腸內幫浦、胰島素幫浦、彈性幫浦、注射式幫浦等。例如，胰島素幫浦是在手術過程中植入皮下的小型裝置，用於為糖尿病患者持續提供胰島素。這些植入式輸液幫浦應用於各個醫療領域，包括腫瘤科、小兒科/新生兒科、胃腸病學、血液科和糖尿病科。它們通常用於醫院、門診手術中心和專科診所等醫療機構，為患者提供有效且精準的藥物輸送。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供植入式輸液泵的市場統計數據，包括全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的植入式輸液泵細分市場、市場趨勢和商機，以及您在植入式輸液泵行業取得成功所需的數據。本植入式輸液幫浦市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為6.9%，較我們先前對該市場的預測略有下降0.2%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會直接波及美國，導致來自義大利和荷蘭等主要地區的蠕動微泵和可再填充藥室的供應鏈中斷，從而可能減少痙攣管理方案，並增加鞘內給藥的成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也可能更為廣泛。

慢性疼痛、癌症和糖尿病等慢性疾病的日益普及預計將推動對植入式輸液幫浦的需求。輸液幫浦通常用於注射治療這些疾病的藥物。由於老化和生活方式的改變，全球慢性疾病和殘疾的逐漸增加凸顯了對此類醫療設備的需求。例如，根據美國癌症協會在 2022 年 1 月發布的報告，預計 2022 年美國將新增 190 萬例癌症病例，並有 609,360 人死亡。此外，估計將有 10,470 名兒童和 5,480 名青少年罹患癌症。慢性病的增加預計將大大促進植入式輸液幫浦市場的成長。

預計老齡人口的不斷成長將進一步推動植入式輸液泵市場的成長。植入式輸液幫浦廣泛用於管理慢性疾病，這對於日益成長的老齡化人口至關重要，因為他們可以從這些設備中受益。根據世界衛生組織（WHO）2022年10月發布的報告，預計到2030年，全球六分之一的人口將年齡在60歲或以上，而2020年至2050年間，80歲或以上人口的數量將增加4.26億。預計到2050年，全球60歲或以上人口將達到21億，老齡化社會可能會繼續推動對植入式輸液幫浦的需求。

植入式輸液幫浦產業的公司越來越重視智慧輸液幫浦的開發。無線技術在醫療監測設備的應用日益廣泛，提升了設備的可用性、連接性和數據分析能力。無線技術的整合使得數據可以透過藍牙或行動電話連接從設備無縫傳輸到智慧型手機和其他無線設備。這有助於數據處理、顯示和後續分析，從而檢查個人的健康狀況。此外，軟體平台也在不斷創新，以實現患者監測並減少過程中出現人為錯誤的可能性。

為了擴大客戶群、推動銷售並增加收益，植入式輸液幫浦市場的主要企業正專注於開發新產品，例如胰島素幫浦。胰島素幫浦是一種旨在幫助糖尿病患者管理血糖值的醫療設備。值得注意的是，2023 年 4 月，總部位於愛爾蘭的醫療設備公司Medtronic宣布其 MiniMed 780G 系統獲得 FDA核准，該系統採用進餐檢測技術。該產品的與眾不同之處在於，它提供市面上所有自動胰島素幫浦中最低的血糖目標值（低至 100 mg/dL），旨在密切反映非糖尿病患者的平均血糖濃度。該系統以目標治療為基礎運行，自動調整和自動校正基礎胰島素以達到特定目標。此外，它是唯一一款配備輸液器的泵，可舒適地佩戴長達七天。這種延長的配戴時間得益於先進的材料，這些材料可最大限度地減少胰島素儲存溶液的損失，保持穩定的胰島素流量和穩定性，並降低輸液器堵塞的可能性。

2022年3月，總部位於巴黎的醫療設備和醫療保健解決方案製造商Vygon SAS收購了Macatt Medica Peruana SAC，收購金額未揭露。此次收購旨在增強Vygon的產品系列，擴大其市場覆蓋範圍，整合創新技術，並提升其競爭地位。總部位於秘魯的Macatt Medica Peruana SAC專注於先進醫療設備的開發和製造，特別專注於用於直接給藥的輸液系統。

企業發展式輸液幫浦市場的主要企業包括美敦力公司 (Medtronic PLC)、波士頓科學公司 (Boston Scientific Corporation)、Nevro Corp、LivaNova PLC、百特國際公司 (Baxter International Inc.)、B. Braun Melsungen AG、Fresenius Kabi AG、史密斯集團 (Smiths Group) 旗下的醫療保健公司 (Johnrumson Johnson)、Greatbatch Medical、NeuroPace Inc.、Primetech Corporation、Flowonix Medical Inc.、F. Hoffmann-La Roche Ltd.、深圳邁瑞生物醫療電子股份有限公司 (Shenzhen Mindray Bio-Medical Electronics Co.Ltd.)、Micrel Medical、Insulet Corporation、ICU Medical Inc.、Becton Dick醫生 Medical. (Abbott Laboratories)、Hospira、史賽克公司 (Stryker Corporation)、Zimmer Biomet Holdings Inc.、泰利福公司 (Teleflex Incorporated)、CR Bard Inc.、AngioDynamics Inc.、Merit Medical Systems Inc.、NIPRO Medical Corporation、IRadimed Corporation、Zyno Medical、Tricumed Inc.

2024年，植入式輸液幫浦市場最大的地區是北美。亞太地區是植入式輸液幫浦市場的第二大地區。植入式輸液幫浦市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美、中東和非洲。

植入式輸液幫浦市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大

植入式輸液幫浦市場涵蓋患者自控鎮痛 (PCA) 幫浦、腸內幫浦、胰島素幫浦、彈性幫浦和注射式幫浦等設備的銷售。該市場中的商品價值為出廠價，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式輸液幫浦：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球植入式輸液幫浦市場：成長率分析
  • 全球植入式輸液幫浦市場表現：規模與成長，2019-2024
  • 全球植入式輸液幫浦市場預測：規模與成長，2024-2029年，2034年
  • 全球植入式輸液幫浦：總目標市場（TAM）

第6章 市場細分

  • 全球植入式輸液幫浦市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 病人自控鎮痛（PCA）泵
  • 腸內泵
  • 胰島素幫浦
  • 彈性體泵
  • 注射式幫浦
  • 其他類型
  • 全球植入式輸液幫浦市場：應用、效能及預測，2019-2024年、2024-2029年、2034年
  • 腫瘤學
  • 小兒科或新生兒科
  • 胃腸病學
  • 血液學
  • 糖尿病
  • 其他用途
  • 全球植入式輸液幫浦市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 專科診所
  • 全球植入式輸液幫浦市場：病人自控鎮痛 (PCA) 幫浦細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 氫可酮PCA泵
  • FentanylPCA泵
  • 其他鴉片類藥物 PCA 泵
  • 全球植入式輸液幫浦市場：按腸內幫浦類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 管飼幫浦
  • 注射器式腸內泵
  • 定期或間歇供料泵
  • 全球植入式輸液幫浦市場：按胰島素幫浦類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 胰島素輸注泵
  • 胰島素貼片幫浦
  • 智慧胰島素泵
  • 全球植入式輸液幫浦市場：依彈性體幫浦類型、性能與預測細分，2019-2024 年、2024-2029 年、2034 年
  • 一次性彈性體泵
  • 可重複使用的彈性體泵
  • 全球植入式輸液幫浦市場：細分注射式幫浦（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 小容量注射式幫浦
  • 大容量注射式幫浦
  • 全球植入式輸液幫浦市場：按類型（其他）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 化療輸液泵
  • 抗生素輸液泵
  • 疼痛管理泵

第7章 區域和國家分析

  • 全球植入式輸液幫浦市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式輸液幫浦市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式輸液幫浦市場：競爭格局
  • 植入式輸液幫浦市場：公司簡介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical, a Smiths Group company
  • Terumo Corporation
  • Johnson & Johnson
  • Greatbatch Medical
  • NeuroPace Inc.
  • Primetech Corporation
  • Flowonix Medical Inc.
  • F. Hoffmann-La Roche Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Micrel Medical
  • Insulet Corporation
  • ICU Medical Inc.
  • Becton Dickinson and Company（BD）

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年植入式輸液幫浦市場：提供新機會的國家
  • 2029年植入式輸液幫浦市場：細分市場帶來新機會
  • 2029年植入式輸液幫浦市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32598u

Implantable infusion pumps are advanced drug delivery systems designed to be surgically implanted within a patient's body. These devices are responsible for controlled and precise administration of medication directly into the bloodstream.

The implantable infusion pumps market is categorized into several types, including patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and other variations. For instance, insulin pumps are small devices implanted under the skin during surgical procedures to continuously deliver insulin for patients with diabetes. These implantable infusion pumps find applications across various medical fields, including oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and more. They are commonly used in healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics to provide effective and precise drug delivery to patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable infusion pumps market size has grown steadily in recent years. It will grow from $19.59 billion in 2024 to $20.32 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to chronic disease management, aging population, pain management, regulatory approvals.

The implantable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $26.49 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include minimally invasive implantation, remote monitoring and programming, intrathecal pain management, interdisciplinary collaboration.

The forecast of 6.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for peristaltic micro-pumps and refillable medication chambers, sourced from key regions such as Italy and the Netherlands, which could lead to reduced options for spasticity management and increased costs for intrathecal drug delivery.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes is anticipated to be a driving force behind the demand for implantable infusion pumps. These pumps are commonly utilized to administer pharmaceutical drugs for treating these ailments. The gradual increase in chronic illnesses and disorders worldwide, primarily attributed to an aging population and shifts in lifestyle, underscores the need for such medical devices. For example, a report published by the American Cancer Society in January 2022 highlighted an anticipated 1.9 million new cancer cases in the US in 2022, with 609,360 projected deaths. An estimated 10,470 pediatric cancer cases and 5,480 teenage cancer diagnoses are also expected. This rise in chronic diseases is projected to significantly contribute to the growth of the implantable infusion pumps market.

The expanding aging population is predicted to further fuel the growth of the implantable infusion pumps market. Implantable infusion pumps are extensively used in the management of chronic conditions, making them crucial for a growing aging demographic that can benefit from these devices. A report by the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally will be 60 or older, while the number of individuals aged 80 or older is estimated to increase by 426 million between 2020 and 2050. With projections indicating 2.1 billion people worldwide aged 60 or older by 2050, the rising aging population will continue to drive the demand for implantable infusion pumps.

Market players in the implantable infusion pump industry are increasingly prioritizing the development of smart infusion pumps. The utilization of wireless technology in healthcare monitoring devices is on the rise, providing improved ease of use, connectivity, and data analysis. Integrating wireless technology allows seamless data transfer from the device to a smartphone or another wireless device using Bluetooth or cellular connections. This facilitates data processing, display, and subsequent analysis for studying the individual's health condition. Moreover, software platforms are being innovated to enable patient monitoring and reduce the occurrence of human error in the process.

Leading companies in the implantable infusion pump market are focusing on the development of new products, such as insulin pumps, to address a broader customer base, boost sales, and increase revenue. Insulin pumps are medical devices designed to assist individuals with diabetes in managing their blood sugar levels. Notably, in April 2023, Medtronic, an Ireland-based medical device company, announced the FDA approval for the MiniMed 780G System featuring meal detection technology. This product distinguishes itself by setting the lowest glucose target (as low as 100 mg/dL) among all automated insulin pumps available in the market, aiming to closely mirror the average glucose levels of individuals without diabetes. The system operates on a treat-to-target basis, automatically making basal insulin adjustments and autocorrections to attain a specific target. Additionally, it stands out as the only pump featuring an infusion set that can be worn comfortably for an extended period of up to 7 days. This extended wear time is facilitated by advanced materials that minimize insulin preservative loss, maintaining consistent insulin flow and stability while reducing the likelihood of infusion set occlusion.

In March 2022, Vygon SAS, a Paris-based manufacturer of medical devices and healthcare solutions, acquired Macatt Medica Peruana SAC for an undisclosed amount. The acquisition aims to bolster Vygon's product portfolio, expand its market reach, integrate innovative technologies, and enhance its competitive position. Macatt Medica Peruana SAC, a Peru-based company, specializes in the development and production of advanced medical devices, with a particular focus on infusion systems for direct medication delivery.

Major companies operating in the implantable infusion pumps market include Medtronic PLC, Boston Scientific Corporation, Nevro Corp, LivaNova PLC, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, NeuroPace Inc., Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Stryker Corporation, Zimmer Biomet Holdings Inc., Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

North America was the largest region in the implantable infusion pumps market in 2024. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Infusion Pumps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable infusion pumps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Other Types
  • 2) By Applications: Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps; Fentanyl PCA Pumps; Other Opioid PCA Pumps
  • 2) By Enteral Pumps: Tube Feeding Pumps; Syringe-based Enteral Pumps; Continuous Or Intermittent Feeding Pumps
  • 3) By Insulin Pumps: Insulin Delivery Pumps; Insulin Patch Pumps; Smart Insulin Pumps
  • 4) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
  • 5) By Syringe Pumps: Small Volume Syringe Pumps; Large Volume Syringe Pumps
  • 6) By Other Types: Chemotherapy Infusion Pumps; Antibiotic Infusion Pumps; Pain Management Pumps
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Nevro Corp; LivaNova PLC; Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Smiths Medical a Smiths Group company; Terumo Corporation; Johnson & Johnson; Greatbatch Medical; NeuroPace Inc.; Primetech Corporation; Flowonix Medical Inc.; F. Hoffmann-La Roche Ltd; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Micrel Medical; Insulet Corporation; ICU Medical Inc.; Becton Dickinson and Company (BD); Roche Diagnostics International AG; Abbott Laboratories; Hospira; Stryker Corporation; Zimmer Biomet Holdings Inc.; Teleflex Incorporated; C. R. Bard Inc.; AngioDynamics Inc.; Merit Medical Systems Inc.; NIPRO Medical Corporation; IRadimed Corporation; Zyno Medical; Tricumed Medizintechnik GmbH; Q Core Medical Ltd.; Ivenix Inc.; Tandem Diabetes Care Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Infusion Pumps Market Characteristics

3. Implantable Infusion Pumps Market Trends And Strategies

4. Implantable Infusion Pumps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Infusion Pumps Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Infusion Pumps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Infusion Pumps Market Growth Rate Analysis
  • 5.4. Global Implantable Infusion Pumps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Infusion Pumps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Infusion Pumps Total Addressable Market (TAM)

6. Implantable Infusion Pumps Market Segmentation

  • 6.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Syringe Pumps
  • Other Types
  • 6.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Pediatrics Or Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes
  • Other Applications
  • 6.3. Global Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • 6.4. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Morphine PCA Pumps
  • Fentanyl PCA Pumps
  • Other Opioid PCA Pumps
  • 6.5. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Enteral Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tube Feeding Pumps
  • Syringe-based Enteral Pumps
  • Continuous or Intermittent Feeding Pumps
  • 6.6. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Delivery Pumps
  • Insulin Patch Pumps
  • Smart Insulin Pumps
  • 6.7. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Elastomeric Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Elastomeric Pumps
  • Reusable Elastomeric Pumps
  • 6.8. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Syringe Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Volume Syringe Pumps
  • Large Volume Syringe Pumps
  • 6.9. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chemotherapy Infusion Pumps
  • Antibiotic Infusion Pumps
  • Pain Management Pumps

7. Implantable Infusion Pumps Market Regional And Country Analysis

  • 7.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Infusion Pumps Market

  • 8.1. Asia-Pacific Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Infusion Pumps Market

  • 9.1. China Implantable Infusion Pumps Market Overview
  • 9.2. China Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Infusion Pumps Market

  • 10.1. India Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Infusion Pumps Market

  • 11.1. Japan Implantable Infusion Pumps Market Overview
  • 11.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Infusion Pumps Market

  • 12.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Infusion Pumps Market

  • 13.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Infusion Pumps Market

  • 14.1. South Korea Implantable Infusion Pumps Market Overview
  • 14.2. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Infusion Pumps Market

  • 15.1. Western Europe Implantable Infusion Pumps Market Overview
  • 15.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Infusion Pumps Market

  • 16.1. UK Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Infusion Pumps Market

  • 17.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Infusion Pumps Market

  • 18.1. France Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Infusion Pumps Market

  • 19.1. Italy Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Infusion Pumps Market

  • 20.1. Spain Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Infusion Pumps Market

  • 21.1. Eastern Europe Implantable Infusion Pumps Market Overview
  • 21.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Infusion Pumps Market

  • 22.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Infusion Pumps Market

  • 23.1. North America Implantable Infusion Pumps Market Overview
  • 23.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Infusion Pumps Market

  • 24.1. USA Implantable Infusion Pumps Market Overview
  • 24.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Infusion Pumps Market

  • 25.1. Canada Implantable Infusion Pumps Market Overview
  • 25.2. Canada Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Infusion Pumps Market

  • 26.1. South America Implantable Infusion Pumps Market Overview
  • 26.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Infusion Pumps Market

  • 27.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Infusion Pumps Market

  • 28.1. Middle East Implantable Infusion Pumps Market Overview
  • 28.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Infusion Pumps Market

  • 29.1. Africa Implantable Infusion Pumps Market Overview
  • 29.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Infusion Pumps Market Competitive Landscape
  • 30.2. Implantable Infusion Pumps Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Nevro Corp Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Infusion Pumps Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Fresenius Kabi AG
  • 31.3. Smiths Medical, a Smiths Group company
  • 31.4. Terumo Corporation
  • 31.5. Johnson & Johnson
  • 31.6. Greatbatch Medical
  • 31.7. NeuroPace Inc.
  • 31.8. Primetech Corporation
  • 31.9. Flowonix Medical Inc.
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.12. Micrel Medical
  • 31.13. Insulet Corporation
  • 31.14. ICU Medical Inc.
  • 31.15. Becton Dickinson and Company (BD)

32. Global Implantable Infusion Pumps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

34. Recent Developments In The Implantable Infusion Pumps Market

35. Implantable Infusion Pumps Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Infusion Pumps Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Infusion Pumps Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Infusion Pumps Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer